ArticleWorld journal of microbiology & biotechnology2026
Mapping the genomic frontier: a comprehensive bibliometric analysis and thematic evolution of whole-genome sequencing for Mycobacterium tuberculosis (1994-2025).
Article in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Whole-genome sequencing of Mycobacterium tuberculosis (WGS-TB) has revolutionized tuberculosis research by providing high-resolution insights into drug resistance, transmission dynamics, and evolutionary pathways. However, the global research landscape, collaboration networks, and thematic evolution of WGS-TB remain underexplored. A comprehensive dataset of WGS-TB publications was retrieved from Scopus. Analyses were conducted using Bibliometrix for productivity trends, Lotka’s and Bradford’s Laws, normalized word cloud, and thematic mapping; VOSviewer for co-authorship, co-occurrence, bibliographic coupling, and unsupervised term clustering; and CiteSpace for reference co-citation analysis (RCCA) and thematic evolution. Between 1994 and 2025, WGS-TB publications exhibited exponential growth, particularly after 2015. The United States, China, and the United Kingdom were leading contributors, supported by globally connected institutions. Collaboration networks revealed strong North–South partnerships, with South Africa acting as a critical bridge. Keyword and thematic analyses identified dominant themes such as drug resistance, genomics, and epidemiology, with emerging areas including metagenomic sequencing and mutation dynamics. Bradford’s Law identified 12 core journals, while RCCA delineated clusters in drug resistance surveillance and molecular epidemiology. This study offers the first integrative mapping of WGS-TB research, illuminating its thematic evolution, global collaboration structure, and emerging directions in genomic surveillance and precision medicine.
Indexed as
Identifiers
41866595What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.